The medication is indicated for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater in the presence of at least one weight-related comorbidity such as pre-diabetes, type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials
[130] Safe handling practices should be emphasized to prevent accidental exposure or ingestion by unauthorized individuals, particularly children and pets
Still, for patients who have struggled with the reality that obesity often requires lifelong treatment, studies like REVEAL-1 offer something increasingly valuable: another option
This formula uses Setria L-Glutathione, a patented form of glutathione manufactured to meet strict quality and purity standards
Int J Pharm 551:103110